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Abstract  
BACKGROUND: Previous studies reported that familial factors such as birth order and mothers atopy might 
influence cord blood levels and development of allergies.  
AIM: The aim of the study was to evaluate the relationship of cord blood IgE and maternal IgE with birth order and 
mothers history of allergy in Albanian mother/neonate pairs.  
MATERIAL AND METHODS: Study population represented 291 mother-infant pairs. Mothers were interviewed 
with a questionnaire for personal history of allergy and pregnancy history whereas serum IgE levels were 
determined using sandwich IRMA assay. 
RESULTS: The mean level of cIgE in neonates with detectable levels was 1.59 (n = 78). No significant difference 
in means of cIgE was found between first born and later born neonates (p = 0.232) and between neonates of 
mothers with a negative and positive history of allergy (p = 0.125). Also, no significant difference was found 
between means of mIgE by birth order, whereas there was a significant difference of mIgE between mothers with 
and without a history of allergy (p = 0.01). In a group of neonates with detectable cIgE levels, maternal IgE levels 
were moderately correlated with cIgE levels.  
CONCLUSION: Cord blood IgE is not affected by birth order and mothers history of allergy, whereas mothers IgE 
are affected by the history of allergy but not by birth order.   
 
 
 
Introduction 
 
In the recent years, developed countries have 
experienced increases in the prevalence of atopic 
diseases; asthma, eczema and hay fever [1]. Although 
genetic predisposition is a fundamental factor 
governing susceptibility to atopic diseases, the rise in 
atopy has occurred within the too short time frame to 
be explained by a genetic shift in the population, thus 
pointing to environmental or lifestyle changes [2, 3].  
The cord blood immunoglobulin E (cIgE) has 
been investigated as a possible early indicator of 
elevated risk for atopic disease, primarily during 
childhood [4]. Various studies demonstrated that 
elevated cIgE are affected by some different factors 
including maternal, paternal, placenta and fetal 
characteristics although findings on each factor have 
been inconclusive [5-12]. There is evidence that the 
number of siblings and birth order may influence cIgE 
levels and development of allergies, asthma and 
immunologic sensitization [13, 14]. The ‘hygiene 
hypothesis’ proposed by Strachan suggests that birth 
order could be associated with frequency of infection, 
since having older siblings may increase the likelihood 
of infections leading to a protective effect against 
childhood allergic disease [15]. Whereas, “in utero 
programming hypotheses” alternatively proposed that 
the sibling effect is related to inherent differences in 
immune function [13].  
In Kosovo, there are no data about the 
prevalence of allergic disease. Taking into account the 
geographic proximity with Albania and genetic 
similarities of the Albanian population in Kosovo with 
Albanian population in Albania, we can assume that 
prevalence of allergic diseases in Kosovo may be as 
low as the prevalence of allergic diseases in Albania 
[16-19]. Also, in Kosovo, there are no data about the 
factors which can influence cIgE levels.  
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The aim of the current study was to evaluate 
the possible influence of birth order and maternal 
history of allergy on cIgE and maternal 
immunoglobulin E (mIgE) as well as the correlation 
between cIgE and mIgE in Albanian mother/neonate 
pairs. 
 
 
Material and Methods 
 
Study population 
Pregnant women coming to the delivery room 
in Obstetrics and Gynecology Clinic of the University 
Clinical Center of Kosovo were screened for eligibility 
for the study. Women with physiologic pregnancy, 
vaginal route of delivery and no evidence of multiple 
gestations and fetal congenital anomaly were eligible. 
Written informed consent for participation in the study 
was obtained from 306 pregnant women. In the 
course of data collection and analysis 15 mother–
infant pairs were excluded from the study: four 
mother–infant pairs due to infants’ cord blood IgE 
greater than 10 kU/L, suspected of possible 
contamination with maternal blood, two mother–infant 
pairs because infants cord blood was not obtained, 
and nine were excluded due to missing data. The 
remaining 291 mother-infant pairs represented our 
study population. Considering that the total annual 
number of newborns in  Kosovo is around 35,000, this 
sample is quite representative.  
This study followed the principles of the 
Declaration of Helsinki and was approved by the 
University Institutional Review Board.  
 
Data Collection and grouping 
After informed consent had been obtained, 
mothers were interviewed with a detailed 
questionnaire for personal allergy history and 
pregnancy history. Pregnancy histories included 
information about the number and outcomes of all 
prior pregnancies including those not carried to term. 
Using this information, neonates were assigned a birth 
order group: no prior pregnancies were labelled as 
“first born neonates” and one or more live birth as 
“later born neonates”; whereas, according to the 
history of allergy, mothers were assigned as “positive 
or “negative”.  
 
Blood collection 
To determine maternal total serum IgE, after 
delivery, blood samples (5 ml) were collected from the 
cubital vein into a non-heparinized tube. Neonatal 
blood (5 ml) was collected from the cord vein by 
venipuncture at the cut end of the cord attached to the 
placenta once the placenta was delivered. After 
centrifugation at 350 g, sera from the blood were 
aliquoted into 2ml vials for IgE estimation and stored 
at -20°C till analysis. 
 
Serum IgE immunoradiometric assays 
(IRMA) 
Serum IgE levels were determined using 
sandwich IRMA assay (Total IgE IRMA, Immunotech, 
Marseille, France) with a detection level of 0.5 kIU/L.  
 
Statistical analysis 
Statistical analyses were done for the 
population of 291 mother-child pairs. Cord blood IgE 
levels were analysed as dependent variable whereas 
maternal IgE levels were analysed as a factor which 
can affect cIgE levels but also as a variable which can 
be affected by birth order and history of allergy. Cord 
blood IgE levels were dichotomized at the detection 
limit of 0.5 kIU/L as undetectable (<0.5 kIU/l) and 
detectable (≥ 0.5 kIU/L), whereas mIgE were 
dichotomized at the limit of 100 kIU/L as negative (< 
100 kIU/l) and positive (≥ 100 kIU/l). However, cIgE 
and mIgE were mostly used as continuous values. 
According to birth order, neonates were categorized 
as first born neonates and as later born neonates 
(2+). 
To explore the relationship of cord blood IgE 
and mothers, IgE with birth order and mothers history 
of allergy, frequencies, means and correlation 
between cIgE and mIgE were analysed. Frequencies 
of cIgE were analysed for the whole sample of 
neonates (n=291), whereas the means were analysed 
only in the group with detectable levels of cIgE, since 
we were not inclined to work with values assigned to 
undetectable samples. Statistical differences in 
frequencies were tested by Pearson’s Chi-square test, 
whereas differences in means were analysed by one-
way ANOVA. To test for correlation between 
categorical and continuous variables Spearman’s 
correlation method was used whereas statistical 
significance was put on p=0.05. Statistical analyses 
were carried out using SPSS statistical package, 
version 23. 
 
 
Results 
 
Study population 
Two hundred and ninety-one mother-infant 
pairs represented our study population. From 291 
mothers in our study population, 74 (24.7%) were in 
age group 16-23 years, 187 (62.3%) age group 34-33 
years and 39 (13%) were in group 34+, with no 
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statistically significant difference between the 
frequencies of detectable and non-detectable cIgE by 
mothers’ age groups. 
Table 1: Frequencies and means of cIgE 
  
  
Birth order 
Mothers history of                       
allergy 
    Birth 1 Birth 2+ Negative Positive 
a) Frequencies  of cIgE 
Total N 
(%) 
N (%) N (%) N (%) N (%) 
All neonates 
291 
(100.00) 
123 
(42.27) 
168 
(57.73) 
261 
(89.69) 
30 (10.31) 
cIgE < 0.5 
215 
(100.00) 
  90 
(41.86) 
125 
(58.14) 
197 
(91.63) 
18 (8.37) 
cIgE ≥ 0.5 
  76 
(100.00) 
  33 
(43.42) 
  43 
(56.58) 
  64 
(84.21) 
12 (15.79) 
  
p = 0.458 p = 0.068 
b) Means of cIgE          
Neonates with cIgE  ≥0.5 
 
  
                                                  
Mean (N) 1.59 (76) 1.83 (33) 1.41 (43) 1.47 (64) 2.20 (12) 
  
p = 0.232 p = 0.125 
Neonates of mothers with 
mIgE < 100 
                                            
Mean (N) 1.47 (58) 1.88 (25) 1.16 (33) 1.49 (50) 1.36 (8) 
  
 
p = 0.04  P=0.807 
Neonates of mothers 
 with mIgE  ≥ 100 
                                                      
Mean (N) 1.98 (18) 1.67 (8) 2.22 (10) 1.43 (14) 3.89 (4) 
 
 
p = 0.5 p = 0.02 
 
Table 1a presents frequencies of 
dichotomized neonates analysed by birth order and 
maternal history of allergy. From 291 neonates, 76 
(26.12%) had detectable levels of cIgE (≥ 0.5 kIU/L) 
with no significant differences in percentages of 
detectable and non-detectable cIgE by birth order (p = 
0.458) and history of allergy (p = 0.068).  
Table 1b shows means of cIgE only for the 
group of neonates with detectable levels of cIgE 
analysed by birth order and maternal history of 
allergy. The mean level of cIgE in neonates with 
detectable levels was 1.59 (n = 78). Although first 
born neonates had higher mean cIgE compared to 
later born ones (1.83 vs. 1.41), no significant 
difference was found between the means of the two 
groups (p = 0.232). Whereas neonates of mothers 
with a positive history of allergy had higher mean cIgE 
compared to neonates of mothers with a negative 
history of allergy (2.20 vs. 1.47), the difference 
between the means of two groups was non-significant 
(p = 0.125).  
To find exactly which group of neonates 
stratified by mothers IgE affects the relationship of 
cIgE and birth order/history of allergy; the means of 
cIgE between parameters were analysed. It was 
observed that mean cIgE level was higher in neonates 
born by mothers with mIgE ≥ 100 than in neonates 
born by mothers with mIgE < 100 (1.98 vs. 1.47) but 
with no significant difference (p = 0.218, data not 
included in the Table).  
When mean cIgE levels were analysed by 
birth order, there was the statistically significant 
difference between the means of cIgE of neonates 
born by mothers with mIgE < 100, with the values 
higher in first born neonates (p = 0.04). But the 
opposite is true for neonates of mothers with mIgE 
≥100, where the mean levels of cIgE were higher in 
later born neonates (p = 0.5). On the other hand, 
when analyzed by history of allergy, the means of 
cIgE were significantly different in neonates born by 
mothers with mIgE ≥ 100 (p = 0.02), being higher in 
neonates of mothers with positive history of allergy, 
but with no significant difference in neonates born by 
mothers with mIgE < 100 (p = 0.807). 
Table 2: Frequencies and means of mIgE 
    Birth order 
Mothers history of 
allergy  
    Birth 1 Birth 2+ Negative Positive 
a) Frequencies  of mIgE 
Total N 
(%) 
N (%) N (%) N (%) N (%) 
Mothers 
291 
(100.00) 
123 
(42.27) 
168 
(57.73) 261 (89.69) 30 (10.31) 
mIgE < 100 
242 
(100.00) 
101 
(41.74) 
141 
(58.26) 221 (91.32)    21 (8.68) 
mIgE ≥ 100 
49 
(100.00) 
  22 
(44.90) 
  27 
(55.10)    40 (81.63) 
     9 
(18.37) 
  
p = 0.399 p  = 0.042 
b) Means of mIgE          
All mothers           
                             Mean (N) 
52.83 
(291) 
54.71 
(123) 
51.46 
(168) 49.68 (261) 80.12 (30) 
    p>0.05 p=0.01 
Mothers of neonates with 
cIgE<0.5 
     
                             Mean (N) 
47.13 
(215) 
47.70 
(90) 
46.72 
(125) 
45.09 (197) 71.23 (18) 
  
 
p>0.05 p>0.05 
Mothers of neonates with 
cIgE≥0.5 
 
        
                               Mean (N) 
68.13 (76) 
72.59 
(33) 
65.23 (43) 63.73 (64) 93.47 (12) 
  
p>0.05 p>0.05 
 
Table 2a shows that 49 mothers from 291 
(16.84%) had levels of IgE ≥ 100 kIU/L, with no 
statistically significant difference between 
dichotomised frequencies of mIgE by birth order (p = 
0.399), but with statistically significant difference of 
dichotomised frequencies of mIgE by history of allergy 
(p = 0.042). 
The means of mIgE are presented in Table 
2b. The means of mIgE levels were 29.97 in mothers 
with mIgE < 100 and 165.23 in mother’s mIgE ≥ 100. 
Comparing the means of mIgE by birth order no 
significant differences between means were found. 
Whereas, when means of mIgE were compared by 
mothers history of allergy statistically significant 
difference was found (p = 0.01).  
On the other hand, when mIgE levels 
stratified by levels of cIgE were analysed no 
significant statistical differences between birth order 
and history of allergy were observed either in mothers 
of neonates with undetectable cIgE or mothers of 
neonates with detectable cIgE levels.  
In the whole sample of mother/neonate pairs 
(n = 291), positive maternal IgE contributed 
significantly to the positivity of cord blood IgE (rS = 
0.231, p = 0.000, data not included in the table). Fig. 
1A presents the levels of IgE in mothers of neonates 
with detectable levels (68.4 kIU/L, n = 76) and the 
levels of cIgE in neonates with detectable levels (1.6 
kIU/L, n = 76). In this group of neonates (cIgE ≥ 0.5) 
maternal IgE levels were moderately correlated with 
cord blood IgE levels (rS = 0.296, p = 0.009) (Figure 
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1B). 
 
Figure 1: IgE levels in the serum of mothers (mIgE) and cord blood 
IgE (cIgE). A) Maternal IgE levels were significantly higher than 
levels of cIgE (P<0.0001). B) A medium correlation was found 
between maternal IgE and cIgE (p<0.01) 
 
 
 
Discussion 
 
In this study, we found that cIgE levels were 
not normally distributed and that most cIgE levels 
were below 0.5 kIU/L, as stated in previous reports 
[20, 21]. The frequency of newborns with detectable 
levels of cIgE was 26.12% which is higher than 
frequencies reported in several studies which used 
the same cut-off values of 0.5 kIU/L [21, 22], but lower 
than in some other [7, 23, 24] and similar to results of 
Edenharter et al [25]. Whereas, the mean cIgE level 
among detectable samples was 1.59 IU/l, with a range 
of 0.51 to 8.24 kIU/l, similar to findings from Nabavi et 
al. [10] but lower than the one reported by Goldstein 
which resulted from a sample taken from a community 
cohort with high prevalence of asthma [23].  
Several studies have been conducted to 
investigate the effect of parity on cIgE levels and to 
determine whether the sibling effect might be 
mediated in part by in utero programming rather than 
postnatal exposure [26]. Data from several 
investigations show that birth order is associated with 
lower IgE levels in cord blood [14, 20, 26-28] but also, 
there are other studies which found no association 
between birth order and cIgE levels [7, 22, 23]. We 
came across only one study which found that birth 
order is associated with higher cIgE levels [10].  
After the Bergmanini report [20], Karmaus et 
al. were the first ones to analyse the birth order effect 
on cIgE. In 2001 they reported that children born third 
or later were less likely to be in a higher cIgE group 
than first-born children [13]. In another publication, 
Karmaus et al. reported a statistically significant 
correlation between cIgE and birth order of live 
offspring although the correlation they reported was 
very weak (rs = - 0.092, P = 0.008) [29]. The 
correlation found by Karmaus et al. was assumed to 
be the result of changes in the utero environment from 
infections during pregnancy and endocrine changes 
which override the effect of the hygiene hypothesis. 
In contrast to reports from some other regions 
in the world, we did not find a statistically significant 
birth order effect in cIgE. Our results are in line with 
the results reported by Bergmanini [20] and several 
other authors [7, 22, 23] who found a nonsignificant 
relationship between these parameters. Significant 
differences in cIgE levels by birth order were found 
only in neonates born by mothers with mIgE < 100 
and, non-significant difference in neonates born by 
mothers with mIgE > 100. Our results do not support 
the finding by Karmaus et al. that birth order effect on 
cIgE is transmitted through maternal IgE [29]. Despite 
all investigations done so far on the effect of birth 
order on the immune response of neonates, there is 
no exact explanation for mechanisms which underlie 
the relationship between birth order and cIgE. The 
nonsignificant birth order effect on cIgE in our sample 
from a low-income country could explain the low 
prevalence of allergic diseases in our country by 
hygiene hypothesis theory rather than by in utero 
programming hypothesis. 
The mean level of cIgE in a group of neonates 
with cIgE > 0.5 was higher in neonates from mothers 
with a history of allergy but with no significant 
difference with neonates from mothers without a 
history of allergy which is in line with results reported 
by Liu et al. [21]. When neonates with detectable 
levels were stratified by mIgE, we observed 
significantly elevated levels of cIgE only in the group 
of mothers with IgE ≥ 100 kIU/L, with positive allergy 
history, and this is in line with the results of Shah et al. 
[11, 30]. This indicates that the newborns of these 
mothers should be assessed for elevated levels of 
cIgE, to undertake pre-emptive measures against the 
onset of atopic diathesis. 
In the current study, no significant differences 
were found either by frequencies or using mIgE levels 
between mothers of first born neonates and later born 
neonates. The absence of association of mIgE and 
birth order in this study as those found from other 
authors [26, 28] do not support the findings from 
Karmaus et al. who reported that maternal IgE 
decreases with increasing birth order [29]. More 
studies are required to verify the effect of birth order 
on mothers immune response and through that on the 
fetal immune response. 
Many previous studies have reported an 
association between mIgE and cIgE that is 
comparable with our findings suggesting the factors 
from family can induce production of IgE [10, 11, 21, 
23, 26-29, 31]. But, also there is one study which did 
not find a correlation between these two variables 
[32]. A significant difference of mIgE between mothers 
with a history of allergy and mothers without a history 
of allergy and a correlation found between mIgE and 
cIgE in this study show that mIgE was predictive for 
detectable levels of cIgE and suggests that the 
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maternal IgE may influence fetal IgE. One approach to 
explain the correlation assumes that cIgE levels are 
genetically determined [33] whereas other approaches 
go through in utero programming [13, 29]. 
In the group of neonates with cIgE ≥ 0.5 
maternal IgE levels were moderately correlated with 
cIgE levels. The correlation found is unlikely to be due 
to contamination of the neonatal blood with maternal 
blood. However, to rule out maternal contamination of 
the cord blood we did not perform any testing knowing 
that maternal IgE does not cross the placenta [35] and 
because when measured cord blood IgA, the rates of 
contamination were very low [31,36]. Also, the very 
low cIgE in our sample of neonates from mothers with 
mIgE >100 indicate than there is no contamination of 
cord blood with maternal blood. 
 In conclusion, the current study found that 
cIgE were not affected by birth order and mothers 
history of allergy, whereas mIgE were affected by the 
history of allergy but not by birth order. Also, we 
conclude that newborns of mothers with allergy history 
with mIgE > 100 should be assessed for elevated 
levels of cIgE, to undertake pre-emptive measures 
against the onset of atopic diathesis. 
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